TrialClinical drug investigation2025

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Axatilimab in Healthy Japanese Male Participants: Results from a Phase 1, Randomized, Double-Blind, Dose-Escalation Study.

Miwa Haranaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.